Ewing sarcoma A673 cells, TK216-resistant clones
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP341274
下载链接
链接失效反馈官方服务：
资源简介：
TK216 is in phase II clinical trials for the treatment of Ewing sarcoma, although the mechanism of action in cells is still unknown. These samples are from a forward genetic screening using MMR-deficient A673 cells to identify the mechanism of action of TK216 in cells.
创建时间：
2022-06-03
